Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.

@article{Ahrn2009VildagliptinEI,
  title={Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.},
  author={Bo Ahr{\'e}n and A. F. Schweizer and Sylvie Dejager and Beth Elaine Dunning and Peter Nilsson and Margaretha Persson and James E Foley},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2009},
  volume={94 4},
  pages={1236-43}
}
CONTEXT Dipeptidyl peptidase-4 inhibitors act by increasing plasma levels of glucagon-like peptide-1 and suppressing excessive glucagon secretion in patients with type 2 diabetes. However, their effects on the glucagon response to hypoglycemia are not established. OBJECTIVE The aim of the study was to assess effects of the dipeptidyl peptidase-4 inhibitor… CONTINUE READING